Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki
Unlock the market timeline & signal feed
272 signals in the last 90 days.
The order this company entered each market — oldest to newest
86 active postings
35 active postings
Sign up to see the full signal feed
How Novartis's international expansion compares to its competitors
NovartisYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 NovartisYou | 48 | 3 | -13% | 249 | 52 |
Specialist DDIT IES DWO Philippines
View postingMakati, National Capital Region, Philippines · Full-time · yesterday
Global Analytical Science and Tech Lead (m/f/d)
View postingBarcelona, Catalonia, Spain · Full-time · today
Product Operations Manager
View postingBarcelona, Catalonia, Spain · yesterday
At Novartis, we understand that pioneering innovation doesn’t stop with incredible science, it also depends on delivery.People like Martina Scionti, our Global Head of Radioligand Therapy (RLT) Supply Chain, and her team work every day to ensure each dose of RLT, a made-to-order cancer treatment, reaches patients within days of production.We're proud to be recognized by Gartner for Supply Chain - celebrating the incredible work our teams do to deliver medicines to patients around the world, when ...
EndedProud partner. Real inclusion. Real impact.
EndedWelcome to where we thrive together
EndedAI sleep healthcare company HoneyNaps opens new office in Boston's Kendall Square through Korea's Bio-health Global Expansion Program to accelerate U.S. partnerships and commercialization.
ACROBiosystems presented AI-driven protein solutions at AACR 2026, featuring its Acro-AIx system with DeepExp and ProDeSol models for protein design optimization and therapeutic development.
EU launches pilot program for innovative medical devices and diagnostics in Q2, addressing regulatory modernization. Global healthcare trends include AI integration, trade policy impacts, and medical tourism expansion.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Novartis's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
